glp-1 and steroids A Closer Look at the Dermatological Profile of Agonists GLP-1 Drug Savings: A Complete
Description
These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 agonist
The oral Wegovy pill produced an average weight loss of 13.6% over 64 weeks, compared to roughly 15% for the injectable version over 71 weeks
Studies suggest muscle loss with these medications (as indicated by decreases in fat-free mass) ranges from 25% to 39% of the total weight lost over 3672 weeks [173,174]
Some patients report feeling queasy for a few hours after taking the medication, which can sometimes interfere with daily activities
Mental health is not a footnoteits central to success
